Predictors of esophageal cancer risk: Assessment of susceptibility to DNA damage using comet assay

Genes Chromosomes and Cancer

Volumn 44, Issue 4, 2005, Pages 415-422

  Shao, Lina ^a   Lin, Jie ^a   Huang, Maosheng ^a   Ajani, Jaffer A ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYBENZO[A]PYRENE OXIDE; MUTAGENIC AGENT;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER RISK; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; ESOPHAGUS CANCER; FEMALE; GAMMA RADIATION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MAJOR CLINICAL STUDY; MALE; MUTAGEN TESTING; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELLS, CULTURED; COMET ASSAY; CONFIDENCE INTERVALS; DNA DAMAGE; ESOPHAGEAL NEOPLASMS; FEMALE; GAMMA RAYS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUTAGENS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SMOKING; TEXAS;

EID: 26944462674     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20254     Document Type: Article

References (60)

1. Benhamou S, Sarasin A. 2000. Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 462:149-158.
2. Blasiak J, Arabski M, Krupa R, Wozniak K, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Zadrozny M. 2004. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat Res 554:139-148.
3. Blasiak J, Kowalik J, Malecka-Panas E, Drzewoski J, Wojewodzka M. 2000. DNA damage and repair in human lymphocytes exposed to three anticancer platinum drugs. Teratog Carcinog Mutagen 20:119-131.
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. 1991. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287-1289.
5. Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P, Sbrana I, Vecchio D, Puntoni R. 1995. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79:133-135.
6. Bonassi S, Hagmar L, Stromberg U, Montagud AH, Tinnerberg H, Forni A, Heikkila P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE, Norppa H. 2000. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 60:1619-1625.
7. Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR, III, Pedersen NL. 2002. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 122:55-59.
8. Carter CL, Hu N, Wu M, Lin PZ, Murigande C, Bonney GE. 1992. Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J Natl Cancer Inst 84:771-776.
9. Chak A, Lee T, Kinnard MF, Brock W, Faulx A, Willis J, Cooper GS, Sivak MV, Jr., Goddard KA. 2002. Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut 51:323-328.
10. Colleu-Durel S, Guitton N, Nourgalieva K, Legue F, Leveque J, Danic B, Chenal C. 2004. Alkaline single-cell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur J Cancer 40:445-451.
11. Crabb DW, Berk MA, Hall TR, Conneally PM, Biegel AA, Lehman GA. 1985. Familial gastroesophageal reflux and development of Barrett's esophagus. Ann Intern Med 103:52-54.
12. Devasa SS, Blot WJ, Fraumeni JF, Jr. 1998. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053.
13. Dunne AL, Price ME, Mothersill C, McKeown SR, Robson T, Hirst DG. 2003. Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells. Br J Cancer 89:2277-2283.
14. Eng C, Spechler SJ, Ruben R, Li FP. 1993. Familial Barrett's esophagus and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev 2:397-399.
15. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF, Jr. 2003. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404-1413.
16. Enzinger PT, Mayer RJ. 2003. Esophageal cancer. N Engl J Med 49:2241-2252.
17. Gelfand MD. 1983. Barrett's esophagus in sexagenerian identical twins. J Clin Gastroenterol 5:251-253.
18. Goode EL, Ulrich CM, Potter JD. 2002. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530.
19. Hagmar L, Brogger A, Hansteen I, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I. 1994. Cancer risk in humans predicted by increased levels of chromosome aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:2919-2922.
20. Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G, Zhu Y, Miao X, Tan W, Wei Q, Lin D, He F. 2004. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 64:4378-4384.
21. Hsu TC. 1983. Genetic instability in the human population: a working hypothesis. Hereditas 98:1-9.
22. Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, Fu M, Taylor PR. 1992. Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int J Epidemiol 21:877-882.
23. Hu N, Dawsey SM, Wu M, Taylor PR. 1991. Family history of oesophageal cancer in Shanxi Province, China. Eur J Cancer 27:1336.
24. Jankowski JA, Provenzale D, Moayyedi P. 2002. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology 122:588-595.
25. Jaskula-Sztul R, Wierzbicka M, Szyfter W, Szyfter K, Gajecka M, Rydzanicz M. 2005. Reduced DNA repair capacity in laryngeal cancer subjects. Adv Otorhinolaryngol 62:25-37.
26. Jeggo PA, Carr AM, Lehmann AR. 1998. Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia. Trends Genet 14:312-316.
27. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2005. Cancer statistics. CA Cancer J Clin 55:10-30.
28. Jochem VJ, Fuerst PA, Fromkes JJ. 1992. Familial Barrett's esophagus associated with adenocarcinoma. Gastroenterology 102:1400-1402.
29. Kassie F, Parzefall W, Knasmuller S. 2000. Single cell gel electrophoresis assay: a new technique for human biomonitoring studies. Mutat Res 463:13-31.
30. Koch TR. 2003. The changing face of esophageal malignancy. Curr Gastroenterol Rep 5:187-191.
31. Kupfer GM, Naf D, D'Andrea AD. 1997. Molecular biology of Fanconi anemia. Hematol Oncol Clin North Am 11:1045-1060.
32. Lee JM, Lee YC, Yang SY, Yang PW, Luh SP, Lee CJ, Chen CJ, Wu MT. 2001. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer 95:240-246.
33. Li G, He L. 1986. Genes and disease, in Proceedings of the First Sino-American Human Genetics Workshop. Beijing: Science Press, pp. 43-47.
34. Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. 1999. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106:642-649.
35. Luo G, Santoro IM, McDaniel LD, Nishijima I, Mills M, Youssoufian H, Vogel H, Schultz RA, Bradley A. 2000. Cancer predisposition caused by elevated mitotic recombination in bloom mice. Nat Genet 26:424-429.
36. Olive PL, Banath JP, Durand RE. 1990. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat Res 122:86-94.
37. Olliver JR, Hardie LJ, Dexter S, Chalmers D, Wild CP. 2003. DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of oesophagus. Biomarkers 8:509-521.
38. Pathak S, Goodacre A. 1986. Specific chromosome anomalies and predisposition to human breast, renal cell, and colorectal carcinoma. Cancer Genet Cytogenet 19:29-36.
39. Prior A, Whorwell PJ. 1986. Familial Barrett's esophagus? Hepatogastroenterology 33:86-87.
40. Romero Y, Cameron AJ, Locke GR, Schaid DJ, Slezak JM, Branch CD, Melton LJ, III. 1997. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 113:1449-1456.
41. Schabath MB, Spitz MR, Grossman HB, Zhang K, Dinney CP, Zheng PJ, Wu X. 2003. Genetic instability in bladder cancer assessed by the Comet assay. J Natl Cancer lnst 95:540-547.
42. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. 2000. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119:333-338.
43. Shen JC, Loeb LA. 2000. The Werner syndrome gene: the molecular basis of RecQ helicase-deficiency diseases. Trends Genet 16:213-220.
44. Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-189.
45. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206-221.
46. Tonin PN. 2000. Genes implicated in hereditary breast cancer syndromes. Semin Surg Oncol 18:281-286.
47. Udumudi A, Jaiswal M, Rajeswari N, Desai N, Jain S, Balakrishna N, Rao KV, Ahuja YR. 1998. Risk assessment in cervical dysplasia patients by single cell gel electrophoresis assay: a study of DNA damage and repair. Mutat Res 412:195-205.
48. Vizcaino AP, Moreno V, Lambert R, Parkin DM. 2002. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 99:860-868.
49. Wang Y, Han XY, Su W, Wang Y, Zhu Y, Sasaba T, Nakachi K, Hoshivama Y, Tagashira Y. 1992. Esophageal cancer in Shanxi Province, People's Republic of China: a case-control study in high and moderate risk areas. Cancer Causes Control 3:107-113.
50. Wei JT, Shaheen NJ. 2003. The changing epidemiology of esophageal adenocarcinoma. Semin Gastrointest Dis 14:112-127.
51. Wild CP, Hardie LJ. 2003. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 3:676-685.
52. Wu AH, Wan P, Bernstein L. 2001. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 12:721-732.
53. Wu M, Hu N, Wang XQ. 1983. Familial cancer, in 1st International Research Conference. Boca Raton, FL: CRC Press, pp. 187-200.
54. Wu X, Gu J, Hong WK, Lee JJ, Amos CI, Jiang H, Winn RJ, Fu KK, Cooper J, Spitz MR. 1998. Benzo[α]pyrene diol eopxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer lnst 90:1393-1399.
55. Wu X, Roth JA, Zhao H, Luo S, Zheng YL, Chiang S, Spitz MR. 2005. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res 65:349-357.
56. Xing DY, Tan W, Song N, Lin DX. 2001. Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 95:140-143.
57. Yang PG, Davis S. 1988. Incidence of cancer of the esophagus in the US by histologic type. Cancer 61:612-617.
58. Yu HP, Zhang XY, Wang XL, Shi LY, Li YY, Li F, Su YH, Wang YJ, Lu B, Sun X, Lu WH, Xu SQ. 2004. DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect Prev 28:194-199.
59. Zeka A, Gore R, Kriebel D. 2003. Effects of alcohol and tobacco on aerodigestive cancer risks: a meta-regression analysis. Cancer Causes Control 14:897-906.
60. Zhang H, Buchholz TA, Hancock D, Spitz MR, Wu X. 2000. γ-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. Int J Oncol 17:399-404.